Literature DB >> 9618296

Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death.

Y Liu1, A M Sun, L D Dworkin.   

Abstract

Hepatocyte growth factor (HGF) is a pleiotropic factor that plays an essential role in renal tubular repair and regeneration following injury. Studies indicate that administration of exogenous HGF to animals stimulates renal epithelial cell DNA synthesis and accelerates recovery from acute renal failure (ARF). However, whether increased cell proliferation accounts for all of the beneficial effects of HGF in ARF is unknown. In this study, we demonstrate that HGF protects renal epithelial cells from undergoing apoptotic cell death. Treatment of renal epithelial mIMCD-3 cells with 25 microM cisplatin in the serum-free medium induced significant apoptosis, as assessed by fluorescent Dye H-33342 staining, TUNEL staining, light and electron microscopy, and DNA laddering analysis. However, constitutive expression of HGF by transfection in mIMCD-3 cells resulted in resistance to cisplatin-induced apoptotic death. The survival rate of HGF-producing C1 cells was more than 2-fold greater as compared to control, mIMCD-3 cells following treatment with 25 microM cisplatin for 2 days. These results suggest that HGF may not only activate tubular repair processes but also ameliorate the initial injury by protecting renal epithelial cells from undergoing apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618296     DOI: 10.1006/bbrc.1998.8676

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage.

Authors:  David Tulasne; Julien Deheuninck; Filipe Calheiros Lourenco; Fabienne Lamballe; Zongling Ji; Catherine Leroy; Emilie Puchois; Anice Moumen; Flavio Maina; Patrick Mehlen; Véronique Fafeur
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

2.  Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.

Authors:  A Fornoni; H Li; A Foschi; G E Striker; L J Striker
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

3.  Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

Authors:  T Nakamura; S Mizuno; K Matsumoto; Y Sawa; H Matsuda; T Nakamura
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

4.  Dephosphorylated Ser985 of c-Met is associated with acquired resistance to rechallenge injury in rats that had recovered from uranyl acetate-induced subclinical renal damage.

Authors:  Tomoyuki Fujikura; Akashi Togawa; Yuan Sun; Takamasa Iwakura; Hideo Yasuda; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2012-12-19       Impact factor: 2.801

5.  Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Vladimir M Subbotin; Tadahiro Uemura; Michael Nalesnik; Anthony J Demetris; John J Fung; Thomas E Starzl
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

6.  An implantable vascularized protein gel construct that supports human fetal hepatoblast survival and infection by hepatitis C virus in mice.

Authors:  Martha J Harding; Christin M Lepus; Thomas F Gibson; Benjamin R Shepherd; Scott A Gerber; Morven Graham; Frank X Paturzo; Christoph Rahner; Joseph A Madri; Alfred L M Bothwell; Brett D Lindenbach; Jordan S Pober
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

7.  Role of Bcl-xL induction in HGF-mediated renal epithelial cell survival after oxidant stress.

Authors:  Jinglan Zhang; Junwei Yang; Youhua Liu
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  tPA protects renal interstitial fibroblasts and myofibroblasts from apoptosis.

Authors:  Kebin Hu; Ling Lin; Xiaoyue Tan; Junwei Yang; Guojun Bu; Wendy M Mars; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121

9.  Cisplatin nephrotoxicity: molecular mechanisms.

Authors:  Marie H Hanigan; Prasad Devarajan
Journal:  Cancer Ther       Date:  2003

10.  Met activation is required for early cytoprotection after ischemic kidney injury.

Authors:  Sherene Mason; Carlos Hader; Arnaud Marlier; Gilbert Moeckel; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.